Technical Analysis for AMRN - Amarin Corporation plc

Grade Last Price % Change Price Change
grade B 24.12 4.92% 1.13
AMRN closed up 4.92 percent on Friday, December 13, 2019, on 1.2 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
See historical AMRN trend table...

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish 0.00%
New 52 Week Closing High Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Overbought Stochastic Strength 0.00%
MACD Bearish Signal Line Cross Bearish 4.92%
180 Bullish Setup Bullish Swing Setup 4.92%
NR7 Range Contraction 4.92%
Overbought Stochastic Strength 4.92%
Golden Cross Bullish 5.74%
New Uptrend Bullish 5.74%
Older signals for AMRN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and therapeutic benefits of polyunsaturated fatty acids. The company lead product comprises Vascepa, a prescription-only omega-3 fatty acid comprising icosapent ethyl as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It also engages in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is headquartered in Dublin, Ireland.
Biopharmaceutical Organic Compounds Nutrition Cardiovascular Diseases Cholesterol Low Density Lipoprotein Lipids Hypertriglyceridemia Saturated Fat

Is AMRN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 24.67
52 Week Low 11.78
Average Volume 9,486,517
200-Day Moving Average 18.26
50-Day Moving Average 18.64
20-Day Moving Average 22.01
10-Day Moving Average 22.58
Average True Range 1.10
ADX 26.77
+DI 34.25
-DI 14.24
Chandelier Exit (Long, 3 ATRs ) 21.38
Chandelier Exit (Short, 3 ATRs ) 22.21
Upper Bollinger Band 24.32
Lower Bollinger Band 19.70
Percent B (%b) 0.96
BandWidth 20.98
MACD Line 1.28
MACD Signal Line 1.23
MACD Histogram 0.0522
Fundamentals Value
Market Cap 6.53 Billion
Num Shares 271 Million
EPS -0.31
Price-to-Earnings (P/E) Ratio -77.81
Price-to-Sales 5.87
Price-to-Book 0.00
PEG Ratio -1.74
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 25.88
Resistance 3 (R3) 25.70 24.93 25.58
Resistance 2 (R2) 24.93 24.49 25.02 25.48
Resistance 1 (R1) 24.53 24.21 24.73 24.71 25.39
Pivot Point 23.76 23.76 23.87 23.85 23.76
Support 1 (S1) 23.36 23.32 23.56 23.54 22.85
Support 2 (S2) 22.59 23.04 22.68 22.76
Support 3 (S3) 22.19 22.59 22.66
Support 4 (S4) 22.37